Pacira BioSciences SVP Lauren Riker sells $217,920 in stock Read More: Pacira BioSciences SVP Lauren Riker sells $217,920 in stock
Topline Data from Phase 2b Studies Inform HBV Functional Cure Strategy; Additional Data Expected in 2H 2026 Emerging Discovery Programs Build Momentum BRII-5395 mRNA Cancer Vaccine…
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE. Pacific Biosciences of California is currently working…
Avidity Biosciences stock hits all-time high at 71.81 USD Read More: Avidity Biosciences stock hits all-time high at 71.81 USD By Investing.com